Advances in Protein Chemistry and Structural Biology
Overview
Advances in Protein Chemistry and Structural Biology is a renowned scientific journal that publishes cutting-edge research in the fields of protein chemistry and structural biology. It covers a wide range of topics, including protein structure determination, protein folding, protein-protein interactions, and protein engineering. With its emphasis on advancing our understanding of protein function and structure, this journal serves as a valuable resource for researchers, academics, and professionals in the field.
Details
Details
Abbr.
Adv Protein Chem Struct Biol
Publisher
Elsevier
Start
2008
End
Continuing
Frequency
Irregular
p-ISSN
1876-1623
e-ISSN
1876-1631
Country
Netherlands
Language
English
Specialty
Biochemistry
Metrics
Metrics
h-index / Ranks: 4133
83
SJR / Ranks: 1813
1573
CiteScore / Ranks: 2299
7.90
Recent Articles
1.
2.
Kar S, Verma D, Mehrotra S, Prajapati V
Adv Protein Chem Struct Biol
. 2025 Feb;
144:77-150.
PMID: 39978976
Over the years, extensive research has been dedicated to performing in-depth analysis of cancer to uncover the intricate details of its nature - including the types of cancer, causative agents,...
3.
Sapra L, Srivastava R
Adv Protein Chem Struct Biol
. 2025 Feb;
144:461-491.
PMID: 39978975
Osteoporosis, a progressive skeletal disorder characterized by decreased bone mass and increased fracture risk, has traditionally been treated with pharmacological agents targeting bone remodeling. However, emerging research highlights the critical...
4.
Choubey R, Sweta , Vibha , Sharma A, Rai A
Adv Protein Chem Struct Biol
. 2025 Feb;
144:431-460.
PMID: 39978974
CD5 is a pan T-cell marker expressed by all T-cells and a subset of B-cells, i.e., B1a cells. The significance of CD5 is evident from its functions, starting from T-cell...
5.
Rai P, Mehrotra S, Prajapati V
Adv Protein Chem Struct Biol
. 2025 Feb;
144:389-429.
PMID: 39978973
Infectious diseases continue to pose significant challenges to global health, especially with the rise of antibiotic resistance and emerging pathogens. Traditional treatments, while effective, are often limited in the face...
6.
Tiwari R, Singh V, Gautam V, Mehrotra S, Kumar R
Adv Protein Chem Struct Biol
. 2025 Feb;
144:355-388.
PMID: 39978972
Host-directed immunotherapy (HDI) is emerging as a transformative strategy in managing chronic diseases by leveraging the host's immune system to combat disease. This innovative approach has shown promise in a...
7.
Baghel K, Mehrotra S, Prajapati V
Adv Protein Chem Struct Biol
. 2025 Feb;
144:331-353.
PMID: 39978971
Pancreatic cancer remains one of the most lethal malignancies, with a five-year survival rate among the lowest of all cancers. This poor prognosis is largely due to the aggressive nature...
8.
Yadav A, Bhagat K, Sharma A, Padhi A
Adv Protein Chem Struct Biol
. 2025 Feb;
144:33-76.
PMID: 39978970
Immunotherapy, harnessing components like antibodies, cells, and cytokines, has become a cornerstone in treating diseases such as cancer and autoimmune disorders. Therapeutic antibodies, in particular, have transformed modern medicine, providing...
9.
Mehrotra S, Kaur N, Kaur S, Matharoo K, Pandey R
Adv Protein Chem Struct Biol
. 2025 Feb;
144:287-329.
PMID: 39978969
The field of cancer therapeutics has witnessed significant advancements over the past decades, particularly with the emergence of immunotherapy. This chapter traces the transformative journey from traditional antibody-based therapies to...
10.
Malemnganba T, Pandey A, Mishra A, Mehrotra S, Prajapati V
Adv Protein Chem Struct Biol
. 2025 Feb;
144:259-286.
PMID: 39978968
Immunotherapy has emerged as a hallmark of hope in the formidable battle against solid tumors such as breast cancer, colorectal cancer, etc., with antibody-drug conjugates (ADCs) starting a new era...